Wilson disease in children: analysis of 57 cases

Nina Manolaki1, Georgia Nikolopoulou, George L Daikos

  • 1First Department of Pediatrics, Athens University, Aghia Sophia Children's Hospital, Athens, Greece.

Insights

Diagnosing Wilson disease (WD) in children is challenging due to varied symptoms. Genetic testing is crucial for confirming the diagnosis in ambiguous pediatric cases.

Area of Science:

  • Pediatric Hepatology
  • Genetic Metabolic Disorders
  • Clinical Diagnostics

Background:

  • Wilson disease (WD) presents with diverse clinical symptoms in children, often making early diagnosis difficult.
  • Asymptomatic cases and varied presentations complicate the diagnostic process in pediatric populations.

Observation:

  • This study analyzed 57 children diagnosed with WD, with a mean age of 9.27 years.
  • Diagnosis was achieved through clinical presentation, abnormal liver function tests, family screening, and specific laboratory markers.
  • Diagnostic criteria included Kayser-Fleischer rings, low serum ceruloplasmin, elevated urinary copper excretion, and liver copper content.

Findings:

  • Genetic analysis proved essential for diagnosing 2 children with equivocal test results (serum ceruloplasmin 26 mg/dL).
  • No direct correlation was observed between specific genetic mutations and the clinical phenotype of WD.
  • Chelating therapy demonstrated good tolerance and satisfactory outcomes in the studied pediatric cohort.

Implications:

  • Wilson disease diagnosis in children necessitates comprehensive evaluation due to its often subtle presentation.
  • Genetic analysis plays a vital role in confirming WD in cases with unclear laboratory findings.
  • Effective management with chelating agents leads to positive outcomes in pediatric Wilson disease.
Abstract

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...